Zasocitinib Shows Strong Efficacy in Plaque Psoriasis in Phase 3 trials
Two Phase 3 clinical studies evaluated the efficacy and safety of zasocitinib in patients with moderate to severe plaque psoriasis and found promising results. Approximately 70% of participants receiving once-daily…